GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity
Año publicación: 2025
Nombre investigadores: Aikaterini Motso, Benjamin Pelcman, Anastasia Kalinovich, Nour Aldin Kahlous, Muhammad Hamza Bokhari, Nodi Dehvari, Carina Halleskog, Erik Waara, Jasper de Jong, Elizabeth Cheesman, Christine Kallenberg, Gopala Krishna Yakala, Praerona Murad, Erika Wetterdal, Pia Andersson, Sten van Beek, Anna Sandström, Diane Natacha Alleluia, Emanuela Talamonti, Sonia Youhanna, Pierre Sabatier, Claire Koenig, Sabine Willems, Aurino M Kemas, Dana S Hutchinson, Seungmin Ham, Lukas Grätz, Jan Voss, Jose G Marchan-Alvarez, Martins Priede, Krista Jaunsleine, Jana Spura, Vadims Kovada, Linda Supe, Leigh A Stoddart, Nicholas D Holliday, Phillip T Newton, Nicolas J Pillon, Gunnar Schulte, Roger J Summers, Ilga Mutule, Edgars Suna, Jesper V Olsen, Peter Molenaar, Jens Carlsson, Volker M Lauschke, Shane C Wright, Tore Bengtsson